Ingenus Pharmaceuticals Llc FDA Record
- Latest inspection VAI · Oct 3, 2024
- No warning letters matched by name
Ingenus Pharmaceuticals Llc has 6 FDA recalls, 4 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Ingenus Pharmaceuticals Llc" is on file.
- Latest recall
- D-0010-2023 · Class II · Sep 30, 2022
- Latest inspection
- Oct 3, 2024 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 6 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 4 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Ingenus Pharmaceuticals Llc: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 2 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 2 | 0 |
| 2018 | 0 | 0 | 0 | 2 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Ingenus Pharmaceuticals Llc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Ingenus Pharmaceuticals Llc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0010-2023 | Class II | Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus… | Sep 30, 2022 |
| D-0374-2022 | Class II | Clobetasol Propionate Foam, 0.05%, packaged in a) 50 g can (NDC 50742-304-50), and b) 100 g can (NDC… | Jan 10, 2022 |
| D-0146-2020 | Class II | Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50… | Oct 9, 2019 |
| D-1058-2019 | Class III | Diclofenac Sodium Topical Solution, 1.5% w/w, 5 FL. OZ. (150 mL) bottle, Rx Only, Manufactured for… | Mar 18, 2019 |
| D-0891-2018 | Class II | Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial, Rx Only… | Jun 8, 2018 |
| D-0890-2018 | Class II | Irinotecan Hydrochloride Injection, USP, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial, Rx Only… | Jun 8, 2018 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Oct 3, 2024 | Barbengo, Switzerland | Drugs | Voluntary Action Indicated (VAI) | 3005403232 |
| Dec 3, 2019 | Barbengo, Switzerland | Drugs | No Action Indicated (NAI) | 3005403232 |
| Oct 31, 2017 | Barbengo, Switzerland | Drugs | Voluntary Action Indicated (VAI) | 3005403232 |
| Nov 4, 2014 | Barbengo, Switzerland | Drugs | Voluntary Action Indicated (VAI) | 3005403232 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3005403232 | Barbengo, Switzerland | 4 | Oct 3, 2024 |
Ingenus Pharmaceuticals Llc and the FDA: common questions
Has Ingenus Pharmaceuticals Llc received an FDA warning letter?
No FDA warning letter addressed to the name "Ingenus Pharmaceuticals Llc" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Ingenus Pharmaceuticals Llc received an FDA Form 483?
FDA has not published a Form 483 for "Ingenus Pharmaceuticals Llc" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Ingenus Pharmaceuticals Llc?
The most recent FDA inspection on file ended Oct 3, 2024 at Barbengo, Switzerland and was classified VAI. FDA has 4 inspections of Ingenus Pharmaceuticals Llc on file.
Has Ingenus Pharmaceuticals Llc had an FDA recall?
Yes. Ingenus Pharmaceuticals Llc has 6 FDA recalls on record. The most recent started Sep 30, 2022.
Need more than this page shows? Ask about Ingenus Pharmaceuticals Llc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.